FDA Examination Finds Substandard Conditions at Contractor’s Plant for J&J Vaccine Production

Vials of the Johnson & Johnson’s single-dose vaccine in the United States. Johnson & Johnson via AP

A contract plant that was producing materials for Johnson & Johnson’s (J&J) CCP virus vaccines failed to meet sanitary standards, according to federal health authorities.

The U.S. Food and Drug Administration (FDA) conducted an examination of the Emergent BioSolutions manufacturing facility after production was put on pause last Friday, according to an SEC filing.